Table 3b:
Covariate | AKD (n=297) | No AKD (n=231) | Difference in means | 95% CI | P-value |
---|---|---|---|---|---|
Age at AKI diagnosis (months) | 45.8 | 45.3 | −0.5 | −10.9 – 9.8 | 0.923 |
BMI (kg/m2) | 15.4 | 15.7 | 0.3 | −0.8 – 1.4 | 0.574 |
AKI duration (days) | 6.1 | 4.5 | −1.5 | −1.9 – −1.2 | <0.001 |
Total number of nephrotoxic medication exposures in AKI period | 8.7 exposures | 7.2 exposures | −1.4 | −2.8 – −0.1 | 0.034 |
Number of contrast studies in AKI period | 0.2 studies | 0.3 studies | 0.1 | −0.03 – 0.2 | 0.167 |